Association of genetic variants with dyslipidemia

Abe,Shintaro; Tokoro,Fumitaka; Matsuoka,Reiko; Arai,Masazumi; Noda,Toshiyuki; Watanabe,Sachiro; Horibe,Hideki; Fujimaki,Tetsuo; Oguri,Mitsutoshi; Kato,Kimihiko; Minatoguchi,Shinya; Yamada,Yoshiji

doi:10.3892/mmr.2015.4081

Association of genetic variants with dyslipidemia

Authors:
- Shintaro Abe
- Fumitaka Tokoro
- Reiko Matsuoka
- Masazumi Arai
- Toshiyuki Noda
- Sachiro Watanabe
- Hideki Horibe
- Tetsuo Fujimaki
- Mitsutoshi Oguri
- Kimihiko Kato
- Shinya Minatoguchi
- Yoshiji Yamada
View Affiliations

Affiliations: Department of Cardiology, Gifu Prefectural General Medical Center, Gifu, Gifu 500‑8717, Japan, Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, Tajimi, Gifu 507‑8522, Japan, Department of Cardiovascular Medicine, Inabe General Hospital, Inabe, Mie 511‑0428, Japan, Department of Cardiology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi 453‑8511, Japan, Department of Internal Medicine, Meitoh Hospital, Nagoya, Aichi 465‑0025, Japan, Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Gifu 501‑1194, Japan, Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 514‑8507, Japan
Published online on: July 16, 2015 https://doi.org/10.3892/mmr.2015.4081
Pages: 5429-5436

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although genetic variants, which regulate lipid metabolism, have been extensively investigated in Caucasian populations, the genes, which confer susceptibility to dyslipidemia in Japanese individuals, remain to be elucidated. The aim of the present study was to examine a possible association among hypertriglyceridemia, hypo‑high density lipoprotein (HDL)‑cholesterolemia or hyper‑low density lipoprotein (LDL)‑cholesterolemia in Japanese individuals with 29 polymorphisms observed to confer susceptibility for coronary heart disease. This was performed through meta‑analyses of genome‑wide association studies in Caucasian populations. The study population comprised 2,354 individuals with dyslipidemia (hypertriglyceridemia, hypo‑HDL‑cholesterolemia or hyper‑LDL‑cholesterolemia) and 3,106 control individuals. To compensate for multiple comparisons of genotypes, a false discovery rate (FDR) of <0.05 was adopted to determine the statistical significance of the associations. Comparisons of allele frequencies using the χ2 test revealed that rs964184 of zinc finger gene (ZPR1; FDR=2.1x10‑7), rs4845625 of interleukin 6 receptor (IL6R; FDR=0.032), rs46522 of ubiquitin‑conjugating enzyme E2Z gene (UBE2Z; FDR=0.032) and rs17514846 of furin (FDR=0.041) were significantly associated with hypertriglyceridemia. The χ2 test revealed that rs599839 of proline/serine‑rich coiled‑coil 1 (PSRC1; FDR=0.004) and rs2075650 of translocase of outer mitochondrial membrane 40 homolog (TOMM40; FDR=0.004) were significantly associated with hyper‑LDL‑cholesterolemia. Multivariate logistic regression analysis with adjustment for age, gender and body mass index revealed that rs964184 of ZPR1 (P=5.1x10‑7; odds ratio, 1.37; dominant model), rs4845625 of IL6R (P=0.0019, odds ratio, 1.25; dominant model) and rs46522 of UBE2Z (P=0.0039, odds ratio, 1.19; dominant model) were significantly associated with hypertriglyceridemia, and that rs599839 of PSRC1 (P=0.0004, odds ratio, 0.70; dominant model) and rs2075650 of TOMM40 (P=0.0004, odds ratio, 1.43; dominant model) were significantly associated with hyper‑LDL‑cholesterolemia. Therefore, ZPR1, IL6R, and UBE2Z may be susceptibility loci for hypertriglyceridemia, whereas PSRC1 and TOMM40 may be such loci for hyper-LDL-cholesterolemia in Japanese individuals.

View Figures

View References

1	Heller DA, de Faire U, Pedersen N, Dahlén G and McClearn GE: Genetic and environmental influences on serum lipid levels in twins. N Eng J Med. 328:1150–1156. 1993. View Article : Google Scholar
2	Pérusse L, Rice T, Després JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH and Bouchard C: Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipase in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 17:3263–3269. 1997. View Article : Google Scholar
3	Global Lipids Genetics Consortium; Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, et al: Discovery and refinement of loci associated with lipid levels. Nat Genet. 45:1274–1283. 2013. View Article : Google Scholar : PubMed/NCBI
4	Kirillova OO: Modern concepts of gene polymorphism, which regulate lipid metabolism. Vopr Pitan. 81:48–52. 2012.
5	Fujimaki T, Kato K, Oguri M, Yohida T, Horibe H, Yokoi K, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, et al: Association of polymorphism of BTN2A1 with dyslipidmemia in East Asian populations. Exp Ther Med. 2:745–749. 2011.PubMed/NCBI
6	Horibe H, Ueyama C, Fujimaki T, Oguri M, Kato K, Ichihara S and Yamada Y: Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals. Mol Med Rep. 9:808–812. 2014.PubMed/NCBI
7	Hiramatsu M, Oguri M, Kato K, Horibe H, Fujimaki T, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, Shin DJ, et al: Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome. Int J Mol Med. 30:185–192. 2012.PubMed/NCBI
8	Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, et al: Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 43:333–338. 2011. View Article : Google Scholar : PubMed/NCBI
9	CARDIoGRAMplusC4D Consortium; Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, et al: Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 45:25–33. 2013. View Article : Google Scholar
10	Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M and Inoko H: High-throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. 57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
11	Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, et al: Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 30:2264–2276. 2010. View Article : Google Scholar : PubMed/NCBI
12	Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
13	Nakayama K, Yanagisawa Y, Ogawa A, Ishizuka Y, Munkhtulga L, Charupoonphol P, Supannnatas S, Kuartei S, Chimedregzen U, Koda Y, et al: High prevalence of an anti-hypertriglyceridemic variant of the MLXIPL gene in Central Asia. J Hum Genet. 56:828–833. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, et al: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 41:56–65. 2009. View Article : Google Scholar
15	Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
16	Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, et al: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 40:161–169. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N and Chen BS: Apolipoprotein A5 gene polymorphism -1131T->C: Association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med. 43:607–612. 2005. View Article : Google Scholar
18	Klos KL, Sing CF, Boerwinkle E, Hamon SC, Rea TJ, Clark A, Fornage M and Hixson JE: Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipo-protein levels in CARDIA participants. Arterioscler Thromb Vasc Biol. 26:1828–1836. 2006. View Article : Google Scholar : PubMed/NCBI
19	Ken-Dror G, Goldbourt U and Dankner R: Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins. J Hum Genet. 55:300–307. 2010. View Article : Google Scholar : PubMed/NCBI
20	Jakel H, Nowak M, Helleboid-Chapman A, Fruchart-Najib J and Fruchart JC: Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann Med. 38:2–10. 2006. View Article : Google Scholar : PubMed/NCBI
21	Galernabi M, Lor K, Jin J, Chai F and Santanam N: The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research. Clin Biohem. 46:12–19. 2013. View Article : Google Scholar
22	Vargas VR, Bonatto SL, Macagnan FE, Feoli AM, Alho CS, Santos ND and Schmitt VM: Influence of the 48867 A>C (Asp358Ala) IL6R polymorphism on response to a lifestyle modification intervention in individuals with metabolic syndrome. Genet Mol Res. 12:3893–3991. 2013. View Article : Google Scholar
23	Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, et al: Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf). 65:88–91. 2006. View Article : Google Scholar
24	Hardardόttir I, Grünfeld C and Feingold KR: Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol. 5:207–215. 1994. View Article : Google Scholar
25	Chu NF, Lin FH, Chin HC and Hong YJ: Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan. Lipids Health Dis. 10:1362011. View Article : Google Scholar : PubMed/NCBI
26	Jiang CQ, Lam TH, Liu B, Lin JM, Yue XJ, Jin YL, Cheung BM and Thomas GN: Interleukin-6 receptor gene polymorphism modulates interleulin-6 levels and the metabolic syndrome: GBCS-CVD. Obesity (Silver Spring). 18:1969–1974. 2010. View Article : Google Scholar
27	Gu X, Zhao F, Zheng M, Fei X, Chen X, Huang S, Xie Y and Mao Y: Cloning and characterization of a gene encoding the human putative ubiquitin conjugating enzyme E2Z (UBE2Z). Mol Biol Rep. 34:183–188. 2007. View Article : Google Scholar
28	Alssema M, Rijkelijkhuizen JM, Holst JJ, Teerlink T, Scheffer PG, Eekhoff EM, Gastaldelli A, Mari A, Hart LM, Nijpels G, et al: Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT. Eur J Endocrinol. 169:421–430. 2013. View Article : Google Scholar : PubMed/NCBI
29	International Consortium for Blood Pressure Genome-Wide Association Studies; Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, et al: Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 478:103–109. 2011. View Article : Google Scholar : PubMed/NCBI
30	Turpeinen H, Raitoharju E, Oksanen A, Oksala N, Levula M, Lyytikäinen LP, Järvinen O, Creemers JW, Kähönen M, Laaksonen R, et al: Proprotein convertases in human athero-sclerotic plaques: The overexpression of FURIN and its substrate cytokines BAFF and APRIL. Atherosclerosis. 219:799–806. 2011. View Article : Google Scholar : PubMed/NCBI
31	Samani NJ, Braund PS, Erdmann J, Götz A, Tomaszewski M, Linsel-Nitschke P, Hajat C, Mangino M, Hengstenberg C, Stark K, et al: The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med (Berl). 86:1233–1241. 2008. View Article : Google Scholar
32	Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, et al: Genomewide association analysis of coronary artery disease. N Engl J Med. 357:443–453. 2007. View Article : Google Scholar : PubMed/NCBI
33	Kleber ME, Renner W, Grammer TB, Linsel-Nitschke P, Boehm BO, Winkelmann BR, Bugert P, Hoffmann MM and März W: Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction: The ludwigshafen risk and cardiovascular health study. Atherosclerosis. 209:492–497. 2010. View Article : Google Scholar
34	Muendlein A, Geller-Rhomberg S, Saely CH, Winder T, Sonderegger G, Rein P, Beer S, Vonbank A and Drexel H: Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis. 206:494–499. 2009. View Article : Google Scholar : PubMed/NCBI
35	Wang AZ, Li L, Zhang B, Shen GQ and Wang QK: Association of SNP rs17465637 on chromosome 1q451 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet. 75:475–482. 2011. View Article : Google Scholar : PubMed/NCBI
36	Vincent JB, Skaug J and Scherer SW: The human homologue of flamingo, EGFL2, encode a brain-expressed large cadherin-like protein which epidermal growth factor-like domains and maps to chromosome 1p13.3–p21.1. DNA Res. 7:233–235. 2000. View Article : Google Scholar : PubMed/NCBI
37	Hsieh PC, Chang JC, Sun WT, Hsieh SC, Wang MC and Wang FF: p53 down-stream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway. Oncogene. 26:4928–4940. 2007. View Article : Google Scholar : PubMed/NCBI
38	Strong A and Rader DJ: Sortilin as a regulator of lipoprotein metabolism. Curr Atheroscler Rep. 14:211–218. 2012. View Article : Google Scholar : PubMed/NCBI
39	Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, Sjoegaard SS, Breiderhoff T, Gotthardt M, Lin F, Eilers A, et al: Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci. 10:1449–1457. 2007. View Article : Google Scholar : PubMed/NCBI
40	Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J and Petersen CM: Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 274:8832–8836. 1999. View Article : Google Scholar : PubMed/NCBI
41	Nilsson SK, Christensen S, Raarup MK, Ryan RO, Nielsen MS and Olivecrona G: Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem. 283:25920–25927. 2008. View Article : Google Scholar : PubMed/NCBI
42	Arvind P, Nair J, Jambunathan S, Kakkar VV and Shanker J: CELSR2-PSCR1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort. J Cardiol. 64:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
43	Humphries AD, Streimann IC, Stojanovski D, Johnston AJ, Yano M, Hoogenraad NJ and Ryan MT: Dissection of the mitochondrial import and assembly pathway for human Tom40. J Biol Chem. 280:11535–11543. 2005. View Article : Google Scholar : PubMed/NCBI
44	Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, et al: Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol. 68:1013–1019. 2011. View Article : Google Scholar : PubMed/NCBI
45	Yu CE, Seltman H, Peskind ER, Galloway N, Zhou PX, Rosenthal E, Wijsman EM, Tsuang DW, Devlin B and Schellenberg GD: Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer disease: Pattern of linkage disequilibrium and disease/marker association. Genomics. 89:655–665. 2007. View Article : Google Scholar : PubMed/NCBI
46	Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, et al: Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 298:1300–1311. 2007. View Article : Google Scholar : PubMed/NCBI
47	Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, Christiansen L, Kremer D, van der Breggen R, Suchiman HE, et al: Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell. 10:686–698. 2011. View Article : Google Scholar : PubMed/NCBI
48	Nebel A, Kleindorp R, Caliebe A, Nothnagel M, Blanché H, Junge O, Wittig M, Ellinghaus D, Flachsbart F, Wichmann HE, et al: A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev. 132:324–330. 2011. View Article : Google Scholar : PubMed/NCBI